SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • July 1st, 2022 • X4 Pharmaceuticals, Inc • Biological products, (no disgnostic substances) • Delaware
Contract Type FiledJuly 1st, 2022 Company Industry JurisdictionThis SECURITIES PURCHASE AGREEMENT (this “Agreement”) is made and entered into as of June 30, 2022 by and among X4 Pharmaceuticals, Inc., a Delaware corporation (the “Company”), and the Investors identified on Exhibit A attached hereto (each an “Investor” and collectively the “Investors”).
REGISTRATION RIGHTS AGREEMENTRegistration Rights Agreement • July 1st, 2022 • X4 Pharmaceuticals, Inc • Biological products, (no disgnostic substances) • Delaware
Contract Type FiledJuly 1st, 2022 Company Industry JurisdictionThis REGISTRATION RIGHTS AGREEMENT (this “Agreement”) is made and entered into as of June 30, 2022 by and among X4 Pharmaceuticals, Inc., a Delaware corporation (the “Company”), and the “Investors” named in that certain Securities Purchase Agreement by and among the Company and the Investors, dated as of June 30, 2022 (the “Purchase Agreement”). Capitalized terms used herein have the respective meanings ascribed thereto in the Purchase Agreement unless otherwise defined herein.
AMENDMENT NO. 4 TO LOAN AND SECURITY AGREEMENTLoan and Security Agreement • July 1st, 2022 • X4 Pharmaceuticals, Inc • Biological products, (no disgnostic substances)
Contract Type FiledJuly 1st, 2022 Company IndustryThis Amendment No. 4 to Loan and Security Agreement (the “Fourth Amendment”) is dated as of June 30, 2022 (the “Fourth Amendment Date”) and is entered into by and among X4 PHARMACEUTICALS, INC., a Delaware corporation (the “Company”), and each of its Qualified Subsidiaries, including without limitation X4 THERAPEUTICS, INC. (“Therapeutics”) (hereinafter collectively referred to as the “Borrower”), the several banks and other financial institutions or entities from time to time parties hereto (collectively, referred to as “Lender”) and HERCULES CAPITAL, INC., a Maryland corporation, in its capacity as administrative agent for itself and the Lender (in such capacity, the “Agent”). Capitalized terms used herein without definition shall have the same meanings given them in the Agreement (as defined below).